6 Results for "

VSV-G

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "VSV-G" in MCE Product Catalog:

  • Targets Recommended:
4
4 Cited Publications
Cat. No.: HY-112762
CAS No.: 1450929-77-7
Pureté:  99.14%
Target:  

Arenavirus

Domaines de recherche:  

Infection

LHF-535 is an antiviral agent extracted from patent WO2013123215A2, Compound 38, has EC50s of <1 μM, <1 μM, <1 μM, and 1-10 μM for Lassa, Machupo, Junin, and VSVg virus, respectively .
1
1 Cited Publications
Cat. No.: HY-P0328
CAS No.: 103425-05-4
Target:  

VSV

Domaines de recherche:  

Infection

VSV-G tag Peptide is a 11 amino acid peptide derived from the Vesicular Stomatitis viral glycoprotein. VSV-G tag Peptide can integrate into the cell membranes of animal cells, induce cell fusion, and significantly enhance the efficiency of DNA transfection into animal cells. VSV-G tag Peptide can be used for research on drug delivery .
Cat. No.: HY-P11460
Target:  

Drug Derivative

Domaines de recherche:  

Infection

Vectofusin-1 is a histidine-rich cationic amphipathic peptide derived from the LAH4 (HY-P0311) peptide family, and also acts as a Viral entry enhancer. Vectofusin-1 promotes the adhesion and fusion of retroviral/lentiviral vectors with cell membranes during viral entry, thereby improving transduction efficiency. Vectofusin-1 potently enhances lentiviral transduction of cells .
Cat. No.: HY-130178
CAS No.: 1210501-46-4
Target:  

Endogenous Metabolite

Domaines de recherche:  

Infection

CL-385319 is an N-substituted piperidine compound with inhibitory activity against H5N1 avian influenza A virus infection. CL-385319 exhibited an IC50 of 27.03±2.54 μM against infection of highly pathogenic H5N1 virus in Madin-Darby canine kidney cells (MDCK). CL-385319 had low cytotoxicity with a CC50 of 1.48 mM and was able to inhibit the entry of pseudoviruses carrying H5N1 strains from different sources, but had no inhibitory effect on the entry of VSV-G pseudotyped particles. Pseudoviruses with the M24A mutation in HA1 or the F110S mutation in HA2 were resistant to CL-385319, indicating that these two residues in the cavity region may be critical for the binding of CL-385319 .
Cat. No.: HY-112762A
Pureté:  99.21%
Target:  

Arenavirus

Domaines de recherche:  

Infection

(E)-LHF-535 is the E-isomer of LHF-535. LHF-535 is an antiviral agent extracted from patent WO2013123215A2, Compound 38, has EC50s of <1 μM, <1 μM, <1 μM, and 1-10 μM for Lassa, Machupo, Junin, and VSVg virus, respectively .
Cat. No.: HY-P81031

Host:  

Mouse

Application:  

WB, IP, ICC/IF

Reactivity:  

Species independent